title: A 19-year-old man with sickle cell disease presenting with spinal infarction: a case report.
abstract: BACKGROUND
  Vasculopathy of the large vessels commonly occurs in sickle cell disease, and as a result cerebral infarction is a well characterized complication of this condition. However, spinal infarction appears to be rare. Spinal infarct is infrequent in the non-sickle cell population as well, and accounts for only about 1 percent of all central nervous system infarcts.
  
  
  METHODS
  In the present work, we report the case of a 19-year-old African-American man with sickle cell disease who experienced an anterior spinal infarct and subsequent quadriplegia. He was incidentally noted to be a heterozygote for factor V Leiden. We also reviewed the literature and found two previous cases of spinal cord infarction and sickle hemoglobin. Our literature search did not demonstrate that heterozygocity for factor V Leiden plays an important role in spinal cord infarction.
  
  
  CONCLUSIONS
  The paucity of cases associated with sickle hemoglobin does not allow us to postulate any particular risk factors with sickle cell disease that might predispose patients to spinal cord infarction. Our patient's case raises the question as to whether spinal cord infarction is being missed in individuals with sickle cell disease and neurologic symptoms.
authors: Departments of Pediatrics and Internal Medicine, Division of Hematology and Oncology, University of North Carolina School of Medicine, 170 Manning Drive 1185A, Physician Office Building CB#7236, Chapel Hill, NC 27599-7236, USA. leila.clay@gru.edu.
authors: April
authors: A
authors: Edwards
authors: E Leila Jerome
authors: EL
authors: Clay
authors: Valerie
authors: V
authors: Jewells
authors: Stacie
authors: S
authors: Adams
authors: Regina D
authors: RD
authors: Crawford
authors: Rupa
authors: R
authors: Redding-Lallinger
references: Am J Hematol. 1997 Jan;54(1):12-5
references: 8980255
references: Paraplegia. 1970 Feb;7(4):282-91
references: 5434950
references: Pediatr Hematol Oncol. 1999 Sep-Oct;16(5):469-72
references: 10505325
references: Neurology. 1996 Aug;47(2):321-30
references: 8757000
references: Blood. 2011 Jun 16;117(24):6681-4
references: 21515823
references: Br J Haematol. 2007 Oct;139(1):3-13
references: 17854302
references: Am J Dis Child. 1987 Jun;141(6):612-5
references: 3321974
references: Arch Neurol. 2006 Aug;63(8):1113-20
references: 16908737
references: Am J Med. 2003 Dec 15;115(9):721-8
references: 14693325
references: Stroke. 1978 Jan-Feb;9(1):45-52
references: 622745
references: J Neurol Neurosurg Psychiatry. 2004 Oct;75(10):1431-5
references: 15377691
references: Clin Imaging. 2012 Sep-Oct;36(5):595-8
references: 22920369
references: Am J Pediatr Hematol Oncol. 1982 Winter;4(4):386-94
references: 7168488
references: J Thromb Thrombolysis. 2008 Jun;25(3):288-92
references: 17619828
references: Am J Hematol. 1998 Sep;59(1):46-50
references: 9723576
references: Neurology. 1980 Oct;30(10):1072-6
references: 7191498
references: Blood Coagul Fibrinolysis. 1991 Apr;2(2):341-53
references: 1893065
references: Am J Hematol. 2010 Jul;85(7):467-71
references: 20575037
references: Br J Haematol. 1997 Mar;96(4):854-6
references: 9074431
references: Semin Thromb Hemost. 2011 Apr;37(3):226-36
references: 21455857
references: J Gen Intern Med. 2007 Jan;22(1):151-4
references: 17351858
references: Pediatr Neurol. 2007 Apr;36(4):209-16
references: 17437902